Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafne Capelusnik

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|October 5, 2021
Baseline predictors of different types of treatment success in rheumatoid arthritisDafne Capelusnik, Daniel Aletaha
Annals of the Rheumatic Diseases|September 26, 2025
The likelihood of joint inflammation recurrence in previously affected joints during psoriatic arthritis disease courseMark Berman, Ori Elkayam, Dafne Capelusnik
Autoimmunity Reviews|February 8, 2025
The role of social determinants of health on disease outcomes in axial spondyloarthritis: A narrative reviewDafne Capelusnik, Annelies Boonen, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|July 11, 2025
Does symptom duration impact on treatment response in axial spondyloarthritis? A meta-analysis of randomized controlled trialsDiego Benavent, Victoria Navarro-Compán, Dafne Capelusnik, et al.
Lancet (London, England)|January 11, 2025
Axial spondyloarthritisVictoria Navarro-Compán, Alexandre Sepriano, Dafne Capelusnik, et al.
Joint Bone Spine|June 24, 2023
Looking through the window of opportunity in axial spondyloarthritis?Diego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
Seminars in Arthritis and Rheumatism|April 26, 2021
Peripheral arthritis and higher disease activity lead to more functional impairment in axial spondyloarthritis: Longitudinal analysis from ESPAXIADafne Capelusnik, Sofia Ramiro, Emilce E Schneeberger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Response to "Refining the Interpretation of Drug Survival and Safety in VEXAS Syndrome: The Importance of Competing Risks and Exposure Time" by Pei Y. et al. and "Reinterpreting the Efficacy of IL-1 Inhibitors in VEXAS Syndrome: A Matter of Superiority or Sequencing?" by Ding Z. et alDafne Capelusnik, Tali Eviatar, Corrado Campochiaro, et al.
RMD Open|September 12, 2022
Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA studyDiego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|January 26, 2024
Thresholds for unacceptable work state in radiographic axial spondyloarthritis of four presenteeism and two clinical outcome measurement instrumentsDafne Capelusnik, Sofia Ramiro, Elena Nikiphorou, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|October 5, 2021
Baseline predictors of different types of treatment success in rheumatoid arthritisDafne Capelusnik, Daniel Aletaha
Annals of the Rheumatic Diseases|September 26, 2025
The likelihood of joint inflammation recurrence in previously affected joints during psoriatic arthritis disease courseMark Berman, Ori Elkayam, Dafne Capelusnik
Autoimmunity Reviews|February 8, 2025
The role of social determinants of health on disease outcomes in axial spondyloarthritis: A narrative reviewDafne Capelusnik, Annelies Boonen, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|July 11, 2025
Does symptom duration impact on treatment response in axial spondyloarthritis? A meta-analysis of randomized controlled trialsDiego Benavent, Victoria Navarro-Compán, Dafne Capelusnik, et al.
Lancet (London, England)|January 11, 2025
Axial spondyloarthritisVictoria Navarro-Compán, Alexandre Sepriano, Dafne Capelusnik, et al.
Joint Bone Spine|June 24, 2023
Looking through the window of opportunity in axial spondyloarthritis?Diego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
Seminars in Arthritis and Rheumatism|April 26, 2021
Peripheral arthritis and higher disease activity lead to more functional impairment in axial spondyloarthritis: Longitudinal analysis from ESPAXIADafne Capelusnik, Sofia Ramiro, Emilce E Schneeberger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Response to "Refining the Interpretation of Drug Survival and Safety in VEXAS Syndrome: The Importance of Competing Risks and Exposure Time" by Pei Y. et al. and "Reinterpreting the Efficacy of IL-1 Inhibitors in VEXAS Syndrome: A Matter of Superiority or Sequencing?" by Ding Z. et alDafne Capelusnik, Tali Eviatar, Corrado Campochiaro, et al.
RMD Open|September 12, 2022
Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA studyDiego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|January 26, 2024
Thresholds for unacceptable work state in radiographic axial spondyloarthritis of four presenteeism and two clinical outcome measurement instrumentsDafne Capelusnik, Sofia Ramiro, Elena Nikiphorou, et al.
Pageof 4